Picture map of Europe with pins indicating European capital cities

Open Access research with a European policy impact...

The Strathprints institutional repository is a digital archive of University of Strathclyde's Open Access research outputs. Strathprints provides access to thousands of Open Access research papers by Strathclyde researchers, including by researchers from the European Policies Research Centre (EPRC).

EPRC is a leading institute in Europe for comparative research on public policy, with a particular focus on regional development policies. Spanning 30 European countries, EPRC research programmes have a strong emphasis on applied research and knowledge exchange, including the provision of policy advice to EU institutions and national and sub-national government authorities throughout Europe.

Explore research outputs by the European Policies Research Centre...

Strathprints

Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles

Dufès, Christine and Muller, Jean-Marc and Couet, William and Olivier, Jean-Christophe and Uchegbu, I.F. and Schätzlein, Andreas G. (2004) Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharmaceutical Research, 21 (1). pp. 101-7. ISSN 0724-8741

[img]
Preview
 PDF (Dufes 2004)
Dufes_et_al2004Doxvesicles.pdf - Final Published Version
Download (222kB) | Preview

Abstract

The study reports the initial biological evaluation of targeted polymeric glycol chitosan vesicles as carrier systems for doxorubicin (Dox). Transferrin (Tf) was covalently bound to the Dox-loaded palmitoylated glycol chitosan (GCP) vesicles using dimethylsuberimidate (DMSI). For comparison, glucose targeted niosomes were prepared using N-palmitoyl glucosamine. Biological properties were studied using confocal microscopy, flow cytometry, and cytotoxicity assays as well as a mouse xenograft model. Tf vesicles were taken up rapidly with a plateau after 1-2 h and Dox reached the nucleus after 60-90 min. Uptake was not increased with the use of glucose ligands, but higher uptake and increased cytotoxicity were observed for Tf targeted as compared to GCP Dox alone. In the drug-resistant A2780AD cells and in A431 cells, the relative increase in activity was significantly higher for the Tf-GCP vesicles than would have been expected from the uptake studies. All vesicle formulations had a superior in vivo safety profile compared to the free drug. The in vitro advantage of targeted Tf vesicles did not translate into a therapeutic advantage in vivo. All vesicles reduced tumor size on day 2 but were overall less active than the free drug.

Item type: Article
ID code: 7826
Keywords: doxorubicin, glucose niosomes, glycol chitosan, polymeric vesicles, transferrin, Pharmacy and materia medica, Organic Chemistry, Pharmaceutical Science, Molecular Medicine, Biotechnology, Pharmacology, Pharmacology (medical)
Subjects: Medicine > Pharmacy and materia medica
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Strathprints Administrator
Date deposited: 03 Apr 2009 14:39
Last modified: 22 Sep 2017 17:30
URI: https://strathprints.strath.ac.uk/id/eprint/7826
Export data:
CORE (COnnecting REpositories)